MBOT (MBOT) Stock Price & Analysis
MBOT (MBOT) rose 4.51% to USD 1.51 as of September 8, 2026 at 19:17 UTC, according to Nexqual real-time market data.
MBOT last closed at USD 1.51; the session ranged USD 1.45–1.52 on volume of 494,749 shares. Market capitalization is —, with a 52-week range of USD 1.44–4.41 (NCM). Source: Nexqual, September 8, 2026 at 19:17 UTC.
Key Statistics (as of September 8, 2026 at 19:17 UTC)
| Price | USD 1.51 |
|---|---|
| Change | ▲ 4.51% (up) |
| Previous Close | USD 1.51 |
| Open | USD 1.51 |
| Day Range | USD 1.45 – 1.52 |
| 52-Week Range | USD 1.44 – 4.41 |
| Volume | 494,749 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (MBOT)
Nexqual's technical model rates MBOT "STRONG SELL" based on 0 bullish and 5 bearish signals across 127 daily candles, as of September 8, 2026 at 19:17 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 44.23 (neutral) |
| vs SMA50 | Below (USD 1.7) |
| MACD | -0.07 (negative) |
From MBOT's Latest SEC 10-K Filing (filed 2026-03-26)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BPTH | Bio-Path Holdings, Inc. | USD 0.03 | ▲ 28.5% |
| MBRX | Moleculin Biotech, Inc. | USD 0.78 | ▲ 15.33% |
| SNOA | Sonoma Pharmaceuticals, Inc. | USD 1.34 | ▲ 1.52% |
| APVO | Aptevo Therapeutics Inc. | USD 1.85 | ▲ 8.19% |
| TENX | Tenax Therapeutics, Inc. | USD 2.01 | ▲ 12.92% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 19:17 UTC. This page is informational and not investment advice.